| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| AJR24409.1 | parS | TZ53_12410 | TZ53_17665 | Hypothetical protein; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | 0.900 |
| AJR24417.1 | parS | TZ53_12450 | TZ53_17665 | RES domain protein; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | 0.672 |
| AJR25282.1 | AJR25283.1 | TZ53_17670 | TZ53_17675 | Prolyl oligopeptidase; Derived by automated computational analysis using gene prediction method: Protein Homology. | TonB-dependent receptor; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.898 |
| AJR25282.1 | parS | TZ53_17670 | TZ53_17665 | Prolyl oligopeptidase; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | 0.545 |
| AJR25282.1 | parT | TZ53_17670 | TZ53_17660 | Prolyl oligopeptidase; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Toxic component of a type II toxin-antitoxin (TA) system. Expression in E.coli inhibits cell growth; bacteriostasis is neutralized by expression of cognate antitoxin ParS. ADP-ribosylates E.coli ribose-phosphate pyrophosphokinase (RPPK, prs) using NAD(+) in vitro; ADP-ribosylates RPPK on 'Lys-182' and 'Ser-202'. Cannot use NADP(+). Also auto-ADP-ribosylates in vitro; in the presence of RPPK auto-ADP-ribosylation decreases; Belongs to the MbcT/ParT/Res family. | 0.545 |
| AJR25283.1 | AJR25282.1 | TZ53_17675 | TZ53_17670 | TonB-dependent receptor; Derived by automated computational analysis using gene prediction method: Protein Homology. | Prolyl oligopeptidase; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.898 |
| AJR25283.1 | parS | TZ53_17675 | TZ53_17665 | TonB-dependent receptor; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | 0.545 |
| AJR25283.1 | parT | TZ53_17675 | TZ53_17660 | TonB-dependent receptor; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Toxic component of a type II toxin-antitoxin (TA) system. Expression in E.coli inhibits cell growth; bacteriostasis is neutralized by expression of cognate antitoxin ParS. ADP-ribosylates E.coli ribose-phosphate pyrophosphokinase (RPPK, prs) using NAD(+) in vitro; ADP-ribosylates RPPK on 'Lys-182' and 'Ser-202'. Cannot use NADP(+). Also auto-ADP-ribosylates in vitro; in the presence of RPPK auto-ADP-ribosylation decreases; Belongs to the MbcT/ParT/Res family. | 0.545 |
| AJR26064.1 | parS | TZ53_00600 | TZ53_17665 | RES domain protein; Derived by automated computational analysis using gene prediction method: Protein Homology. | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | 0.672 |
| parS | AJR24409.1 | TZ53_17665 | TZ53_12410 | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | Hypothetical protein; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.900 |
| parS | AJR24417.1 | TZ53_17665 | TZ53_12450 | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | RES domain protein; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.672 |
| parS | AJR25282.1 | TZ53_17665 | TZ53_17670 | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | Prolyl oligopeptidase; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.545 |
| parS | AJR25283.1 | TZ53_17665 | TZ53_17675 | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | TonB-dependent receptor; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.545 |
| parS | AJR26064.1 | TZ53_17665 | TZ53_00600 | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | RES domain protein; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.672 |
| parS | parT | TZ53_17665 | TZ53_17660 | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | Hypothetical protein; Toxic component of a type II toxin-antitoxin (TA) system. Expression in E.coli inhibits cell growth; bacteriostasis is neutralized by expression of cognate antitoxin ParS. ADP-ribosylates E.coli ribose-phosphate pyrophosphokinase (RPPK, prs) using NAD(+) in vitro; ADP-ribosylates RPPK on 'Lys-182' and 'Ser-202'. Cannot use NADP(+). Also auto-ADP-ribosylates in vitro; in the presence of RPPK auto-ADP-ribosylation decreases; Belongs to the MbcT/ParT/Res family. | 0.998 |
| parT | AJR25282.1 | TZ53_17660 | TZ53_17670 | Hypothetical protein; Toxic component of a type II toxin-antitoxin (TA) system. Expression in E.coli inhibits cell growth; bacteriostasis is neutralized by expression of cognate antitoxin ParS. ADP-ribosylates E.coli ribose-phosphate pyrophosphokinase (RPPK, prs) using NAD(+) in vitro; ADP-ribosylates RPPK on 'Lys-182' and 'Ser-202'. Cannot use NADP(+). Also auto-ADP-ribosylates in vitro; in the presence of RPPK auto-ADP-ribosylation decreases; Belongs to the MbcT/ParT/Res family. | Prolyl oligopeptidase; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.545 |
| parT | AJR25283.1 | TZ53_17660 | TZ53_17675 | Hypothetical protein; Toxic component of a type II toxin-antitoxin (TA) system. Expression in E.coli inhibits cell growth; bacteriostasis is neutralized by expression of cognate antitoxin ParS. ADP-ribosylates E.coli ribose-phosphate pyrophosphokinase (RPPK, prs) using NAD(+) in vitro; ADP-ribosylates RPPK on 'Lys-182' and 'Ser-202'. Cannot use NADP(+). Also auto-ADP-ribosylates in vitro; in the presence of RPPK auto-ADP-ribosylation decreases; Belongs to the MbcT/ParT/Res family. | TonB-dependent receptor; Derived by automated computational analysis using gene prediction method: Protein Homology. | 0.545 |
| parT | parS | TZ53_17660 | TZ53_17665 | Hypothetical protein; Toxic component of a type II toxin-antitoxin (TA) system. Expression in E.coli inhibits cell growth; bacteriostasis is neutralized by expression of cognate antitoxin ParS. ADP-ribosylates E.coli ribose-phosphate pyrophosphokinase (RPPK, prs) using NAD(+) in vitro; ADP-ribosylates RPPK on 'Lys-182' and 'Ser-202'. Cannot use NADP(+). Also auto-ADP-ribosylates in vitro; in the presence of RPPK auto-ADP-ribosylation decreases; Belongs to the MbcT/ParT/Res family. | Hypothetical protein; Antitoxin component of a type II toxin-antitoxin (TA) system. Neutralizes the bacteriostatic effect of cognate toxin ParT by inserting into its active site. | 0.998 |